Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.
Younes A, Oki Y, Bociek RG, Kuruvilla J, Fanale M, Neelapu S, Copeland A, Buglio D, Galal A, Besterman J, Li Z, Drouin M, Patterson T, Ward MR, Paulus JK, Ji Y, Medeiros LJ, Martell RE. Younes A, et al. Among authors: buglio d. Lancet Oncol. 2011 Dec;12(13):1222-8. doi: 10.1016/S1470-2045(11)70265-0. Epub 2011 Oct 25. Lancet Oncol. 2011. PMID: 22033282 Free PMC article. Clinical Trial.
Histone deacetylase inhibitors in lymphoma.
Copeland A, Buglio D, Younes A. Copeland A, et al. Among authors: buglio d. Curr Opin Oncol. 2010 Sep;22(5):431-6. doi: 10.1097/CCO.0b013e32833d5954. Curr Opin Oncol. 2010. PMID: 20683267 Review.
Histone deacetylase inhibitors in Hodgkin lymphoma.
Buglio D, Younes A. Buglio D, et al. Invest New Drugs. 2010 Dec;28 Suppl 1(Suppl 1):S21-7. doi: 10.1007/s10637-010-9588-y. Epub 2010 Dec 3. Invest New Drugs. 2010. PMID: 21127943 Free PMC article. Review.
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma.
Oki Y, Buglio D, Fanale M, Fayad L, Copeland A, Romaguera J, Kwak LW, Pro B, de Castro Faria S, Neelapu S, Fowler N, Hagemeister F, Zhang J, Zhou S, Feng L, Younes A. Oki Y, et al. Among authors: buglio d. Clin Cancer Res. 2013 Dec 15;19(24):6882-90. doi: 10.1158/1078-0432.CCR-13-1906. Epub 2013 Oct 4. Clin Cancer Res. 2013. PMID: 24097867 Free PMC article. Clinical Trial.
ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma.
Batlevi CL, Kasamon Y, Bociek RG, Lee P, Gore L, Copeland A, Sorensen R, Ordentlich P, Cruickshank S, Kunkel L, Buglio D, Hernandez-Ilizaliturri F, Younes A. Batlevi CL, et al. Among authors: buglio d. Haematologica. 2016 Aug;101(8):968-75. doi: 10.3324/haematol.2016.142406. Epub 2016 May 5. Haematologica. 2016. PMID: 27151994 Free PMC article. Clinical Trial.
Novel small-molecule therapy of Hodgkin lymphoma.
Buglio D, Georgakis G, Younes A. Buglio D, et al. Expert Rev Anticancer Ther. 2007 May;7(5):735-40. doi: 10.1586/14737140.7.5.735. Expert Rev Anticancer Ther. 2007. PMID: 17492936 Review.
21 results